News | July 18, 2022
Biotium introduces new line of antibodies for exosome detection
ExoBrite antibody conjugates are validated and optimized for bright and specific detection of exosome markers
ExoBrite antibody conjugates are validated and optimized for bright and specific detection of exosome markers
Jublia (Efinaconazole) topical solution, 10% had annual sales of $292 million in the United States according to IQVIA data (IQVIA MAT May 2022).
Tobacco smoke increases infant morbidity and is fatal to a baby because it damages the baby’s organs
Orion to receive an upfront payment of USD 290 million
Upgrades and global expansion provide additional control, visibility, reliability and recovery for patient-critical, time-and temperature-sensitive products
She joins Enveda from Gilead Sciences
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
Syngene's collaboration with Zoetis started in 2011
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.
Subscribe To Our Newsletter & Stay Updated
